RxDoctor Payments Data

Peter Michael, MD

Pain Medicine · Coral Gables, FLNPI 1972898815

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Konica Minolta Healthcare Americas, Inc at 52.1% of the total. Reporting peaked in 2019 at $2,592 and has fallen 96.2% since, to $99 in 2024.

$4,797in general payments, 2019–2025

Across 39 payments — averaging $123.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Konica Minolta Healthcare Americas, Inc$3K
  • Nalu Medical, Inc.$1K
  • Abbott$219
  • Almatica Pharma LLC$151
  • Scilex Pharmaceuticals Inc.$130
  • Philips North America LLC$101
  • plus $257 from 5 others
$491,004in research payments, 2019–2025

Across 228 payments — averaging $2153.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$446K
  • Indivior Inc.$45K

What the payments were for

  • Speaking & faculty fees$2,50052%
  • Travel & lodging$1,09223%
  • Food & beverage$1,20525%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,797 in reported general payments places this provider in the 65th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$15,963
Medicare patients
47
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib651$17,714
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen601$11,837
OzempicSemaglutide12$10,348
Gabapentin1,791$9,621
Lidocaine125$7,175
Diclofenac Sodium371$5,066
Acetaminophen-CodeineAcetaminophen With Codeine307$4,231
Buprenorphine14$3,821
Tramadol Hcl544$2,762
Pregabalin193$2,567
Naloxone Hcl34$2,494
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen134$1,954
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen210$1,888
Fentanyl24$1,540
Duloxetine Hcl109$888

Paid to pharmacies, not to this prescriber.

Other pain medicine in Coral Gables

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →